MetaADEDB 2.0 @ LMMD
Dobutamine
(BQKADKWNRWCIJL-UHFFFAOYSA-N)
Structure
SMILES
CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O.Cl
Molecular Formula:
C18H24ClNO3
Molecular Weight:
337.841
Log P:
4.1497
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
5
TPSA:
72.72
CAS Number(s):
49745-95-1; 52663-81-7
Synonym(s)
1.
Dobutamine
2.
Dobucor
3.
Dobuject
4.
Dobutamin Fresenius
5.
Dobutamin Hexal
6.
Dobutamin Solvay
7.
Dobutamin-ratiopharm
8.
Dobutamina Inibsa
9.
Dobutamina Rovi
10.
Dobutamine (+)-Isomer
11.
Dobutamine Hydrobromide
12.
Dobutamine Hydrochloride
13.
Dobutamine Lactobionate
14.
Dobutamine Phosphate (1:1) Salt, (-)-Isomer
15.
Dobutamine Tartrate
16.
Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer
17.
Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer
18.
Dobutamine, (-)-Isomer
19.
Dobutamine, Phosphate (1:1) Salt (+)-Isomer
20.
Dobutrex
21.
Lilly 81929
22.
Oxiken
23.
Posiject
24.
Dobutamin ratiopharm
25.
Hydrobromide, Dobutamine
26.
Hydrochloride, Dobutamine
27.
Lactobionate, Dobutamine
28.
Tartrate, Dobutamine
External Link(s)
MeSHD004280
PubChem Compound46878359
54759025
65324
ChEBI4671
CHEMBLCHEMBL1200418
KEGGdr:D00632
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Atrial FibrillationFAERS: 29US FAERS
2Chest PainFAERS: 13US FAERS
3HeadacheFAERS: 12US FAERS
4Medication ErrorFAERS: 12US FAERS
5Cardiac procedure complicationFAERS: 11US FAERS
6Drug ineffectiveFAERS: 9US FAERS
7Eosinophilic myocarditisFAERS: 9US FAERS
8HypotensionFAERS: 8US FAERS
9Ventricular FibrillationFAERS: 8US FAERS
10Cardiac ArrestFAERS: 6US FAERS
11Myocardial InfarctionFAERS: 6US FAERS
12Incorrect dose administeredFAERS: 5US FAERS
13Myocardial ruptureFAERS: 5US FAERS
14Product label confusionFAERS: 5US FAERS
15Supraventricular tachycardiaFAERS: 5US FAERS
16Cerebral vasoconstrictionFAERS: 4US FAERS
17Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
18NauseaFAERS: 4US FAERS
19BradycardiaFAERS: 3US FAERS
20ChillsFAERS: 3US FAERS
21Coronary Artery DiseaseFAERS: 3US FAERS
22Drug dispensing errorFAERS: 3US FAERS
23Procedural complicationFAERS: 3US FAERS
24Product packaging confusionFAERS: 3US FAERS
25SepsisFAERS: 3US FAERS
26Wrong drug administeredFAERS: 3US FAERS
27Acute myocardial infarctionFAERS: 2US FAERS
28Drug DependenceFAERS: 2US FAERS
29Ejection Fraction DecreasedFAERS: 2US FAERS
30General physical health deteriorationFAERS: 2US FAERS
31HyperventilationFAERS: 2US FAERS
32Infusion Site ExtravasationFAERS: 2US FAERS
33Infusion site phlebitisFAERS: 2US FAERS
34Left ventricle outflow tract obstructionFAERS: 2US FAERS
35Pericardial effusionFAERS: 2US FAERS
36Product dispensing errorFAERS: 2US FAERS
37Product name confusionFAERS: 2US FAERS
38Product packaging issueFAERS: 2US FAERS
39Product quality issueFAERS: 2US FAERS
40Ventricular arrhythmiaFAERS: 2US FAERS
41VomitingFAERS: 2US FAERS
42Accelerated Idioventricular RhythmFAERS: 1US FAERS
43Accidental exposureFAERS: 1US FAERS
44AgitationFAERS: 1US FAERS
45AkinesiaFAERS: 1US FAERS
46AstheniaFAERS: 1US FAERS
47Atrial FlutterFAERS: 1US FAERS
48Back PainFAERS: 1US FAERS
49Cardiac TamponadeFAERS: 1US FAERS
50Cardiac valve replacement complicationFAERS: 1US FAERS
51Cerebral InfarctionFAERS: 1US FAERS
52Cerebral microhaemorrhageFAERS: 1US FAERS
53Cerebrovascular accidentFAERS: 1US FAERS
54Chest discomfortFAERS: 1US FAERS
55DermatitisFAERS: 1US FAERS
56Device FailureFAERS: 1US FAERS
57Drug effect incompleteFAERS: 1US FAERS
58Drug level below therapeuticFAERS: 1US FAERS
59Electromechanical dissociationFAERS: 1US FAERS
60EmbolismFAERS: 1US FAERS
61Enterococcal infectionFAERS: 1US FAERS
62Enterococcal sepsisFAERS: 1US FAERS
63EosinophiliaFAERS: 1US FAERS
64ExtravasationFAERS: 1US FAERS
65Feeling abnormalFAERS: 1US FAERS
66Fluid overloadFAERS: 1US FAERS
67Gastric DilatationFAERS: 1US FAERS
68HyperkinesiaFAERS: 1US FAERS
69Incorrect drug administration durationFAERS: 1US FAERS
70Incorrect drug administration rateFAERS: 1US FAERS
71Increased ventricular afterloadFAERS: 1US FAERS
72InflammationFAERS: 1US FAERS
73Infusion site erythemaFAERS: 1US FAERS
74Infusion site painFAERS: 1US FAERS
75Infusion site pruritusFAERS: 1US FAERS
76Infusion site swellingFAERS: 1US FAERS
77Intercepted drug prescribing errorFAERS: 1US FAERS
78Intercepted product dispensing errorFAERS: 1US FAERS
79Intercepted product selection errorFAERS: 1US FAERS
80Left Ventricular HypertrophyFAERS: 1US FAERS
81Lip swellingFAERS: 1US FAERS
82Mental status changes postoperativeFAERS: 1US FAERS
83Mitral valve sclerosisFAERS: 1US FAERS
84Musculoskeletal discomfortFAERS: 1US FAERS
85Myocardial bridgingFAERS: 1US FAERS
86No adverse eventFAERS: 1US FAERS
87PO2 decreasedFAERS: 1US FAERS
88PalpitationsFAERS: 1US FAERS
89Pharmaceutical product complaintFAERS: 1US FAERS
90PneumoperitoneumFAERS: 1US FAERS
91Post procedural complicationFAERS: 1US FAERS
92Post procedural strokeFAERS: 1US FAERS
93Product container issueFAERS: 1US FAERS
94Product label issueFAERS: 1US FAERS
95Product outer packaging issueFAERS: 1US FAERS
96Reaction to preservativesFAERS: 1US FAERS
97Respiratory FailureFAERS: 1US FAERS
98Respiratory distressFAERS: 1US FAERS
99Right ventricular failureFAERS: 1US FAERS
100ShockFAERS: 1US FAERS
101Sinus TachycardiaFAERS: 1US FAERS
102SomnolenceFAERS: 1US FAERS
103SyncopeFAERS: 1US FAERS
104Systolic dysfunctionFAERS: 1US FAERS
105TachycardiaFAERS: 1US FAERS
106Therapy non-responderFAERS: 1US FAERS
107TremorFAERS: 1US FAERS
108Troponin I increasedFAERS: 1US FAERS
109Troponin T increasedFAERS: 1US FAERS
110Urinary tract infectionFAERS: 1US FAERS
111Vascular insufficiencyFAERS: 1US FAERS
112VasculitisFAERS: 1US FAERS
113Ventricular DysfunctionFAERS: 1US FAERS
114Ventricular hypokinesiaFAERS: 1US FAERS
115Wrong product storedFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.